Tmunity Therapeutics

Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. Follow @KitePharma for updates.

[Tmunity Therapeutics @TmunityTx]

Tmunity has been acquired by Kite, a Gilead Company. Follow @KitePharma for updates.

[Tmunity Therapeutics @TmunityTx]

Today we welcomed @VijayReddyMD and @SimonaKing3 as our Chief Research Officer and Chief Financial Officer. Let’s cure cancer. #tmunitytx

[Tmunity Therapeutics @TmunityTx]

Happy Administrative Professionals' Day to our fabulous administrative team that keep #Tmunitytx organized and high-functioning every day! #AdministrativeProfessionalsDay #tcell #WhyWeAreHere

[Tmunity Therapeutics @TmunityTx]

The toll of the pandemic is beyond the unfortunate who contact the disease. The ripple effects on cancer patients and others is daunting and real. #cancercare #WhyWeAreHere #tcell

https://t.co/C8lsdKP3NK

[Tmunity Therapeutics @TmunityTx]

#CancerFree #tcell #HERO #WhyWeAreHere @EWhiteheadFdn @carlhjune @BLLPHD

[Emily Whitehead Foundation @EWhiteheadFdn]

On this day in 2012, Emily received her first infusion of the T-cells that saved her life. It is a moment that changed both our family & cancer research.

Today, 8 years later, Emily is healthy and thriving as a freshman in high school. #WeBelieve

[Tmunity Therapeutics @TmunityTx]

National High Five Day was the perfect reason to say #ThankYou #TmunityTx #StayHomeStaySafeSaveLives

[Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 @BLLPHD]

Awesome @Penn #Philly pic!

[Tmunity Therapeutics @TmunityTx]

Tune in at 1:30 PM EST as Tmunity CEO and President @OzAzamTmunity1 takes the stage to discuss next-gen T cell immunotherapies at #Cowen and Company’s 40th Annual Health Care Conference. #tmunitytx Listen here: https://t.co/8znjNIBw4O

[Tmunity Therapeutics @TmunityTx]

Tmunity and CEO @OzAzamTmunity1 are thrilled to be in Boston to attend #Cowen and Company’s 40th Annual Health Care Conference. We’re looking forward to presenting the latest from our research efforts and connecting with investors. #tmunitytx

[Tmunity Therapeutics @TmunityTx]

We’re honored to announce Tmunity President and CEO Dr. Oz Azam has been awarded @LifeSciencesPA’s Frank Baldino Bioscience CEO of the Year Award. His leadership at Tmunity and collaborations with @PennMedicine have been central to our success. #tmunitytx

[Life Sciences PA @LifeSciencesPA]

We are pleased to announce Usman "Oz" Azam, MD, President and CEO, Tmunity Therapeutics Incorporated, has been selected as the recipient of the Frank Baldino Bioscience CEO of the Year Award! Congratulate him at the 2020 Annual Dinner on March 19! https://t.co/CRv3esGLeb

[Jorge Conde @JorgeCondeBio]

Congratulations to @TmunityTx CEO @OzAzamTmunity1 on being named “CEO of the Year” by @LifeSciencesPA!

[Tmunity Therapeutics @TmunityTx]

Tmunity will presenting at two upcoming investor conferences. https://t.co/4oMjSXJeKE

[Tmunity Therapeutics @TmunityTx]

Tmunity celebrates International Day of Women and Girls in Science and the incredible contributions they have made to our world. #WomenInScience #WomenInSTEM #tmunitytx

[Carl June @carlhjune]

Happy to announce that the first trial conducted under approval by the FDA to test multiplex CRISPR genome editing was published online in Science
https://t.co/fZVJhDl3I0
#CRISPR

[a16z @a16z]

CAR T therapy is one of our most powerful new cancer tools—maybe even a cure. With vein-to-vein logistics—removing cells, engineering them, and putting them back in your body—it's not just medicine. It's a whole new paradigm.

New pod: https://t.co/SNkFA900rj

[Tmunity Therapeutics @TmunityTx]

Tmunity CEO Dr. Oz Azam joins Jorge Conde and Hanne Tidnam from @a16z to discuss CAR T therapy and innovation. Listen here: https://t.co/vUEw4rfiUP #TmunityTx #CellTherapy

[Penn Medicine News @PennMedNews]

In an update to a first-in-U.S. #CRISPR trial, @PennCancer researchers show CRISPR-edited immune cells can survive and thrive after they’re infused into cancer patients. With @ParkerICI & @TmunityTX. Via @ScienceMagazine.

[Penn Medicine News @PennMedNews]

@PennCancer @parkerici @TmunityTx @sciencemagazine For more on what makes the potential of CRISPR so exciting, watch the video below. https://t.co/zSe3H4Euov